Common misconceptions

Common mistake
Wrong: The ductus venosus connects the umbilical vein directly to the right atrium.
Right: The ductus venosus shunts oxygenated blood from the umbilical vein into the inferior vena cava, bypassing the hepatic sinusoids.
The ductus venosus doesn't jump straight to the right atrium — it drains into the inferior vena cava, which then carries blood into the right atrium. The point of the ductus venosus is to let oxygenated umbilical vein blood skip the hepatic sinusoids (bypassing the liver's high-resistance vascular bed), not to bypass the IVC entirely. Tracing the path correctly: umbilical vein → ductus venosus → IVC → right atrium.
Common mistake
Wrong: The ductus arteriosus closes because pulmonary vascular resistance rises at birth.
Right: The ductus arteriosus closes because increased arterial pO2 at birth causes smooth muscle contraction; prostaglandins (especially PGE2) had maintained its patency in utero.
Pulmonary vascular resistance actually falls at birth — that's part of what allows the lungs to take over gas exchange — but falling PVR is not the trigger that closes the ductus arteriosus. The direct trigger is rising arterial pO2, which causes smooth muscle in the DA wall to contract. In utero, prostaglandins (especially PGE2 from the placenta) kept that smooth muscle relaxed and the ductus open; once the placenta is delivered and pO2 rises, that tone disappears and the vessel constricts.
Common mistake
Wrong: Indomethacin is used to keep the ductus arteriosus open in duct-dependent lesions.
Right: Indomethacin (a COX inhibitor) closes a PDA; alprostadil (PGE1 analog) is used to keep the ductus open in duct-dependent congenital heart lesions.
Indomethacin is a COX inhibitor — it blocks prostaglandin synthesis, which removes the signal keeping the ductus arteriosus open, so it closes the PDA. Alprostadil is a synthetic PGE1 analog — it mimics prostaglandin action to actively maintain ductal patency. In duct-dependent lesions (like critical pulmonary stenosis or hypoplastic left heart), you need the ductus open to maintain circulation, so you give alprostadil. In a premature infant with an unwanted PDA, you give indomethacin (or ibuprofen) to close it.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. You need to name all three fetal shunts, know where each one connects anatomically, and explain what circulatory problem each one solves in the fetus.
  2. You need to explain the specific physiologic triggers — increased arterial pO2, decreased pulmonary vascular resistance, and loss of prostaglandin tone — that cause each fetal shunt to close at birth, and know which trigger applies to which shunt.
  3. You need to know that indomethacin (a COX inhibitor) closes a patent ductus arteriosus by blocking prostaglandin synthesis, while alprostadil (a PGE1 analog) keeps the ductus open in duct-dependent congenital heart lesions — and be able to choose the right drug given a clinical scenario.

Can you avoid these mistakes?

Trace the path of oxygenated blood from the placenta to the fetal brain, naming every vessel and shunt it passes through in order.
A term neonate is born and begins crying vigorously. What two physiologic changes — one hemodynamic, one chemical — drive closure of the ductus arteriosus over the next hours to days?
A 2-day-old premature infant (28 weeks) has a continuous machinery murmur at the left upper sternal border. Echocardiogram confirms a PDA. What drug class would you use to close it, and what is its mechanism?
A neonate is diagnosed with transposition of the great arteries. The cardiologist orders a continuous IV infusion to maintain ductal patency until surgical repair. What drug is being given, and why would indomethacin be dangerous in this context?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →